Inflammatory properties of antibiotic-treated bacteria

Journal of Leukocyte Biology

Volumn 101, Issue 1, 2017, Pages 127-134

  Wolf, Andrea J ^a,b   Liu, George Y ^b,c   Underhill, David M ^a,b  

^a F Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute   (United States)

^b Division of Research Immunology   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Autolysis; Peptidoglycan; Staphylococcus aureus; lactam

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL CELL WALL; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; BACTERIUM; CELL FUNCTION; CELL INTERACTION; GENE EXPRESSION; HOST CELL; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CELL WALL; DRUG EFFECTS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; PATHOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL WALL; HUMANS; INFLAMMATION; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY;

EID: 85008482338     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4MR0316-153RR     Document Type: Review

References (76)

1. Periti, P., Mazzei, T. (1985) Infections in immunocompromised patients. II. Established therapy and its limitations. Clin. Ther. 8, 100-117.
2. Sakoulas, G., Okumura, C. Y., Thienphrapa, W., Olson, J., Nonejuie, P., Dam, Q., Dhand, A., Pogliano, J., Yeaman, M. R., Hensler, M. E., Bayer, A. S., Nizet, V. (2014) Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J. Mol. Med. 92, 139-149.
3. Müller, S., Wolf, A. J., Iliev, I. D., Berg, B. L., Underhill, D. M., Liu, G. Y. (2015) Poorly cross-linked peptidoglycan in MRSA due to MecA induction activates the inflammasome and exacerbates immunopathology. Cell Host Microbe 18, 604-612.
4. Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., Piddock, L. J. (2015) Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13, 42-51.
5. Tamaoki, J. (2004) The effects of macrolides on inflammatory cells. Chest 125 (2: Suppl) 41S-50S, quiz 51S.
6. Nishio, J., Honda, K. (2012) Immunoregulation by the gut microbiota. Cell. Mol. Life Sci. 69, 3635-3650.
7. Perez-Chanona, E., Trinchieri, G. (2016) The role of microbiota in cancer therapy. Curr. Opin. Immunol. 39, 75-81.
8. Ginsburg, I. (2002) The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae. APMIS 110, 753-770.
9. Moore, L. J., Pridmore, A. C., Dower, S. K., Read, R. C. (2003) Penicillin enhances the Toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. J. Infect. Dis. 188, 1040-1048.
10. Hilmi, D., Parcina, M., Stollewerk, D., Ostrop, J., Josten, M., Meilaender, A., Zaehringer, U., Wichelhaus, T. A., Bierbaum, G., Heeg, K., Wolz, C., Bekeredjian-Ding, I. (2014) Heterogeneity of host TLR2 stimulation by Staphylocoocus aureus isolates. PLoS One 9, e96416.
11. Wolf, A. J., Arruda, A., Reyes, C. N., Kaplan, A. T., Shimada, T., Shimada, K., Arditi, M., Liu, G., Underhill, D. M. (2011) Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J. Immunol. 187, 6002-6010.
12. Holzheimer, R. G. (2001) Antibiotic induced endotoxin release and clinical sepsis: a review. J. Chemother. 13, 159-172.
13. Munford, R. S. (2008) Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect. Immun. 76, 454-465.
14. Dofferhoff, A. S., Nijland, J. H., de Vries-Hospers, H. G., Mulder, P. O., Weits, J., Bom, V. J. (1991) Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand. J. Infect. Dis. 23, 745-754.
15. Simpson, A. J., Opal, S. M., Angus, B. J., Prins, J. M., Palardy, J. E., Parejo, N. A., Chaowagul, W., White, N. J. (2000) Differential antibiotic-induced endotoxin release in severe melioidosis. J. Infect. Dis. 181, 1014-1019.
16. Shenep, J. L., Barton, R. P., Mogan, K. A. (1985) Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J. Infect. Dis. 151, 1012-1018.
17. Seeley, J. J., Ghosh, S. (2013) Tolerization of inflammatory gene expression. Cold Spring Harb. Symp. Quant. Biol. 78, 69-79.
18. English, B. K. (2014) Limitations of beta-lactam therapy for infections caused by susceptible Gram-positive bacteria. J. Infect. 69 (Suppl 1), S5-S9.
19. Tuomanen, E., Liu, H., Hengstler, B., Zak, O., Tomasz, A. (1985) The induction of meningeal inflammation by components of the pneumococcal cell wall. J. Infect. Dis. 151, 859-868.
20. Nau, R., Wellmer, A., Soto, A., Koch, K., Schneider, O., Schmidt, H., Gerber, J., Michel, U., Brück, W. (1999) Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J. Infect. Dis. 179, 1557-1560.
21. Mustafa, M. M., Ramilo, O., Mertsola, J., Risser, R. C., Beutler, B., Hansen, E. J., McCracken, G. H. Jr. (1989) Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J. Infect. Dis. 160, 818-825.
22. Kadurugamuwa, J. L., Hengstler, B., Zak, O. (1989) Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J. Infect. Dis. 159, 26-34.
23. Chávez-Bueno, S., McCracken, G. H. Jr. (2005) Bacterial meningitis in children. Pediatr. Clin. North Am. 52, 795-810, vii.
24. Baudoux, P., Bles, N., Lemaire, S., Mingeot-Leclercq, M. P., Tulkens, P. M., Van Bambeke, F. (2007) Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections. J. Antimicrob. Chemother. 59, 246-253.
25. Høiby, N., Bjarnsholt, T., Givskov, M., Molin, S., Ciofu, O. (2010) Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents 35, 322-332.
26. Rybak, M. J. (2006) The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin. Infect. Dis. 42 (Suppl 1), S35-S39.
27. Andersson, D. I., Hughes, D. (2014) Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12, 465-478.
28. Keller, N., Raponi, G., Hoepelman, I. M., Overbeek, B. P., Rozenberg-Arska, M., Verhoef, J. (1991) Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes. Zentralbl. Bakteriol. 274, 519-526.
29. Gemmell, C. G., O’Dowd, A. (1983) Regulation of protein A biosynthesis in Staphylococcus aureus by certain antibiotics: its effect on phagocytosis by leukocytes. J. Antimicrob. Chemother. 12, 587-597.
30. Knudsen, G. M., Holch, A., Gram, L. (2012) Subinhibitory concentrations of antibiotics affect stress and virulence gene expression in Listeria monocytogenes and cause enhanced stress sensitivity but do not affect Caco-2 cell invasion. J. Appl. Microbiol. 113, 1273-1286.
31. Hernández-Flores, K. G., Vivanco-Cid, H. (2015) Biological effects of listeriolysin O: implications for vaccination. BioMed Res. Int. 2015, 360741.
32. Linares, J. F., Gustafsson, I., Baquero, F., Martinez, J. L. (2006) Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. USA 103, 19484-19489.
33. Rangel, S. M., Logan, L. K., Hauser, A. R. (2014) The ADPribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia. MBio 5, e01080-14.
34. Sutterwala, F. S., Mijares, L. A., Li, L., Ogura, Y., Kazmierczak, B. I., Flavell, R. A. (2007) Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204, 3235-3245.
35. Aminov, R. I. (2009) The role of antibiotics and antibiotic resistance in nature. Environ. Microbiol. 11, 2970-2988.
36. Ji, G., Beavis, R., Novick, R. P. (1997) Bacterial interference caused by autoinducing peptide variants. Science 276, 2027-2030.
37. Velarde, J. J., Ashbaugh, M., Wessels, M. R. (2014) The human antimicrobial peptide LL-37 binds directly to CsrS, a sensor histidine kinase of group A Streptococcus, to activate expression of virulence factors. J. Biol. Chem. 289, 36315-36324.
38. Walker, M. J., Hollands, A., Sanderson-Smith, M. L., Cole, J. N., Kirk, J. K., Henningham, A., McArthur, J. D., Dinkla, K., Aziz, R. K., Kansal, R. G., Simpson, A. J., Buchanan, J. T., Chhatwal, G. S., Kotb, M., Nizet, V. (2007) DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat. Med. 13, 981-985.
39. Schlievert, P. M., Kelly, J. A. (1984) Clindamycin-induced suppression of toxic-shock syndrome—associated exotoxin production. J. Infect. Dis. 149, 471.
40. Ohlsen, K., Ziebuhr, W., Koller, K. P., Hell, W., Wichelhaus, T. A., Hacker, J. (1998) Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillinresistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 42, 2817-2823.
41. Kebaier, C., Chamberland, R. R., Allen, I. C., Gao, X., Broglie, P. M., Hall, J. D., Jania, C., Doerschuk, C. M., Tilley, S. L., Duncan, J. A. (2012) Staphylococcus aureus a-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasome. J. Infect. Dis. 205, 807-817.
42. Sriskandan, S., McKee, A., Hall, L., Cohen, J. (1997) Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes. J. Antimicrob. Chemother. 40, 275-277.
43. Braun, M. A., Gerlach, D., Hartwig, U. F., Ozegowski, J. H., Romagné, F., Carrel, S., Köhler, W., Fleischer, B. (1993) Stimulation of human T cells by streptococcal “superantigen” erythrogenic toxins (scarlet fever toxins). J. Immunol. 150, 2457-2466.
44. Holzinger, D., Gieldon, L., Mysore, V., Nippe, N., Taxman, D. J., Duncan, J. A., Broglie, P. M., Marketon, K., Austermann, J., Vogl, T., Foell, D., Niemann, S., Peters, G., Roth, J., Löffler, B. (2012) Staphylococcus aureus Panton-Valentine leukocidin induces an inflammatory response in human phagocytes via the NLRP3 inflammasome. J. Leukoc. Biol. 92, 1069-1081.
45. Otto, M. P., Martin, E., Badiou, C., Lebrun, S., Bes, M., Vandenesch, F., Etienne, J., Lina, G., Dumitrescu, O. (2013) Effects of subinhibitory concentrations of antibiotics on virulence factor expression by community-acquired methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 68, 1524-1532.
46. Löffler, B., Hussain, M., Grundmeier, M., Brück, M., Holzinger, D., Varga, G., Roth, J., Kahl, B. C., Proctor, R. A., Peters, G. (2010) Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6, e1000715.
47. Wang, R., Braughton, K. R., Kretschmer, D., Bach, T. H., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., DeLeo, F. R., Otto, M. (2007) Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13, 1510-1514.
48. Joo, H. S., Chan, J. L., Cheung, G. Y., Otto, M. (2010) Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 4942-4944.
49. Otto, M., O’Mahoney, D. S., Guina, T., Klebanoff, S. J. (2004) Activity of Staphylococcus epidermidis phenol-soluble modulin peptides expressed in Staphylococcus carnosus. J. Infect. Dis. 190, 748-755.
50. Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., Konradsen, H. B., Nahm, M. H. (2015) Pneumococcal capsules and their types: past, present, and future. Clin. Microbiol. Rev. 28, 871-899.
51. Geisinger, E., Isberg, R. R. (2015) Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 11, e1004691.
52. Llobet, E., Campos, M. A., Giménez, P., Moranta, D., Bengoechea, J. A. (2011) Analysis of the networks controlling the antimicrobial-peptidedependent induction of Klebsiella pneumoniae virulence factors. Infect. Immun. 79, 3718-3732.
53. Gemmell, C. G., Peterson, P. K., Schmeling, D., Mathews, J., Quie, P. G. (1983) Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur. J. Clin. Microbiol. 2, 327-334.
54. Melnikow, E., Schoenfeld, C., Spehr, V., Warrass, R., Gunkel, N., Duszenko, M., Selzer, P. M., Ullrich, H. J. (2008) A compendium of antibiotic-induced transcription profiles reveals broad regulation of Pasteurella multocida virulence genes. Vet. Microbiol. 131, 277-292.
55. Kaplan, J. B. (2011) Antibiotic-induced biofilm formation. Int. J. Artif. Organs 34, 737-751.
56. Hoffman, L. R., D’Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., Miller, S. I. (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436, 1171-1175.
57. Boehm, A., Steiner, S., Zaehringer, F., Casanova, A., Hamburger, F., Ritz, D., Keck, W., Ackermann, M., Schirmer, T., Jenal, U. (2009) Second messenger signalling governs Escherichia coli biofilm induction upon ribosomal stress. Mol. Microbiol. 72, 1500-1516.
58. Burdette, D. L., Vance, R. E. (2013) STING and the innate immune response to nucleic acids in the cytosol. Nat. Immunol. 14, 19-26.
59. Roilides, E., Simitsopoulou, M., Katragkou, A., Walsh, T. J. (2015) How biofilms evade host defenses. Microbiol. Spectr. 3, 1-10.
60. Rybtke, M., Hultqvist, L. D., Givskov, M., Tolker-Nielsen, T. (2015) Pseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune response. J. Mol. Biol. 427, 3628-3645.
61. Scherr, T. D., Heim, C. E., Morrison, J. M., Kielian, T. (2014) Hiding in plain sight: interplay between Staphylococcal biofilms and host immunity. Front. Immunol. 5, 37.
62. Lappin, E., Ferguson, A. J. (2009) Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9, 281-290.
63. Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., Charlier, P. (2008) The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32, 234-258.
64. Beck, W. D., Berger-Bächi, B., Kayser, F. H. (1986) Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of Mec-specific DNA. J. Bacteriol. 165, 373-378.
65. De Jonge, B. L., Tomasz, A. (1993) Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis. Antimicrob. Agents Chemother. 37, 342-346.
66. Shimada, T., Park, B. G., Wolf, A. J., Brikos, C., Goodridge, H. S., Becker, C. A., Reyes, C. N., Miao, E. A., Aderem, A., Götz, F., Liu, G. Y., Underhill, D. M. (2010) Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 7, 38-49.
67. Davis, K. M., Weiser, J. N. (2011) Modifications to the peptidoglycan backbone help bacteria to establish infection. Infect. Immun. 79, 562-570.
68. Ip, W. K., Sokolovska, A., Charriere, G. M., Boyer, L., Dejardin, S., Cappillino, M. P., Yantosca, L. M., Takahashi, K., Moore, K. J., Lacy-Hulbert, A., Stuart, L. M. (2010) Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J. Immunol. 184, 7071-7081.
69. Kaplan, A., Ma, J., Kyme, P., Wolf, A. J., Becker, C. A., Tseng, C. W., Liu, G. Y., Underhill, D. M. (2012) Failure to induce IFN-b production during Staphylococcus aureus infection contributes to pathogenicity. J. Immunol. 189, 4537-4545.
70. Figueiredo, T. A., Ludovice, A. M., Sobral, R. G. (2014) Contribution of peptidoglycan amidation to beta-lactam and lysozyme resistance in different genetic lineages of Staphylococcus aureus. Microb. Drug Resist. 20, 238-249.
71. Cázares-Domínguez, V., Cruz-Córdova, A., Ochoa, S. A., Escalona, G., Arellano-Galindo, J., Rodríguez-Leviz, A., Hernández-Castro, R., López-Villegas, E. O., Xicohtencatl-Cortes, J. (2015) Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening. PLoS One 10, e0118791.
72. Cui, L., Iwamoto, A., Lian, J. Q., Neoh, H. M., Maruyama, T., Horikawa, Y., Hiramatsu, K. (2006) Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50, 428-438.
73. Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M. N., Ploy, M. C., El-Solh, N., Ferraz, V., Hiramatsu, K. (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol. 41, 5-14.
74. Krawczyk-Balska, A., Korsak, D., Popowska, M. (2014) The surface protein Lmo1941 with LysM domain influences cell wall structure and susceptibility of Listeria monocytogenes to cephalosporins. FEMS Microbiol. Lett. 357, 175-183.
75. Jackson, J. J., Kropp, H. (1992) beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J. Infect. Dis. 165, 1033-1041.
76. Kadurugamuwa, J. L., Beveridge, T. J. (1997) Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J. Antimicrob. Chemother. 40, 615-621.